Serum prolidase in myocardial infarction: purification, kinetic properties, and drug-enzyme interactions
New Journal of Chemistry · 2026 · 50 (22) · 9605-9616
DOI: 10.1039/d5nj05027h ↗Kurz gefasst
Fachartikel in der Zeitschrift New Journal of Chemistry, 2026. Verfasst von Lana Abid Mansor Alnajar und 3 weiteren Autor:innen. Die Arbeit nennt 50 Literaturangaben.
Abstract (Originalsprache)
This study focused on the isolation, purification, and biochemical characterization of the prolidase from the serum of patients with myocardial infarction (MI), alongside an in silico evaluation of potential pharmaceutical inhibitors.
Zitieren
APA
Alnajar, L. A. M., Kudhair, A. H., Nouman, A. F., & Azooz, E. A. (2026). Serum prolidase in myocardial infarction: purification, kinetic properties, and drug-enzyme interactions. New Journal of Chemistry, 50(22), 9605-9616. https://doi.org/10.1039/d5nj05027h
Vancouver
Alnajar LAM, Kudhair AH, Nouman AF, Azooz EA. Serum prolidase in myocardial infarction: purification, kinetic properties, and drug-enzyme interactions. New Journal of Chemistry. 2026;50(22):9605-9616. doi:10.1039/d5nj05027h
BibTeX
@article{Alnajar2026,
author = {Alnajar, Lana Abid Mansor and Kudhair, Ahmed Hassan and Nouman, Ansam Faeq and Azooz, Ebaa Adnan},
title = {Serum prolidase in myocardial infarction: purification, kinetic properties, and drug-enzyme interactions},
journal = {New Journal of Chemistry},
year = {2026},
volume = {50},
number = {22},
pages = {9605--9616},
doi = {10.1039/d5nj05027h}
}
EUVIMED